ASRC Press Releases

Beiersdorf Says it Will Discontinue Six-Hour Claim for ‘Aquaphor’ Diaper Rash Cream Following NAD Inquiry

Beiersdorf, Inc., the maker of “Aquaphor Baby Diaper Rash Cream” said it has launched a new advertising campaign and is permanently discontinuing express claims that the product relieves diaper rash in six hours. The company’s statement came in response to an inquiry by NAD.

Read More

ERSP Reviews Advertising for Vaughn College, Recommends Marketer Modify or Discontinue Certain Claims

ERSP has recommended that Vaughn College modify or discontinue certain claims in its advertising.

Read More

NAD Recommends Intraceuticals Discontinue Challenged Claims for ‘Atoxelene’ Products

NAD has recommended that Intraceuticals LLC discontinue certain express and implied claims for the company’s Atoxelene Skin Care Products and Atoxelene Line Wand, including claims that the products work “instantly.” Meanwhile, the advertiser has said it will work to have certain other claims for its products removed from a third-party website that it does not control.

Read More

NAD Recommends Mega-T Discontinue ‘Burns Fat’ Claim; Company Voluntarily Discontinues Certain Other Claims Challenged by CRN

Mega-T, LLC, the maker of “Mega-T Green Tea Fat Burning Supplements,” has said it will permanently discontinue certain advertising claims challenged by the Council for Responsible Nutrition and comply with the recommendations of the National Advertising Division.

Read More

NAD Recommends Clorox Modify Packaging to Clarify Role of Zinc Pyrithione in its ‘Glad Tall Kitchen Drawstring Bags’

NAD has recommended that The Clorox Company modify product packaging and a free-standing insert to better assure that consumers understand that Clorox’s zinc pyrithione (ZPT) works to prevent odors on the drawstring of the company’s “Glad Tall Kitchen Drawstring Bags.”

Read More

NAD Recommends Genomma Modify Current Broadcast Ad for ‘Silka’ to Avoid Certain Comparisons to Other OTC Athlete’s Foot Products

NAD has recommended that Genomma Lab USA, Inc. maker of the athlete’s foot product Silka, modify current advertising claims to eliminate certain comparisons to competing over-the-counter products.

Read More